SESSION DESCRIPTION
This session are outstanding clinical trials in ET and PV. Suggested session title<br /><br /><span style="caret-color: #000000; color: #000000; font-family: Aptos, Aptos_EmbeddedFont, Aptos_MSFontService, Calibri, Helvetica, sans-serif; font-size: 14.666667px; font-style: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration: none; display: inline !important; float: none;">ET and PV: Moving Beyond Conventional Therapy</span>
KEYWORDS
Treatment Considerations, Drug Development, Biological Therapies, Antibody Therapy, Bispecific Antibody Therapy, Adverse Events, Biological Processes, Genomics, Hematopoiesis, Immune Mechanism, Clinical Practice (Health Services and Quality), Diseases, Bleeding and Clotting, Bleeding Disorders, Platelet Disorders, Thromboembolism, Thrombotic Disorders, VWD, Myeloid Malignancies, Chronic Myeloid Malignancies, Research, Translational Research, MDS, MPN, CMML, Clinical Research, Clinical Trials, Study Population, Human, Adult, Elderly, Young Adult